Myomo (MYO) Current Deferred Revenue (2016 - 2025)
Myomo (MYO) posted Current Deferred Revenue of $218222.0 for Q4 2025, up 61.89% on a QoQ basis from $134800.0 in Q3 2025, and up 162.55% year-over-year from $83115.0 in Q4 2024.
Myomo (MYO) Current Deferred Revenue (2016 - 2025) Analysis & Trends
Myomo's Current Deferred Revenue history runs 10 years deep, the most recent figure standing at $218222.0 for Q4 2025.
- Quarterly Current Deferred Revenue rose 162.55% year-over-year to $218222.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $218222.0 (up 162.55% YoY) and the FY2025 annual result came in at $218222.0, up 162.55% from the prior year.
- Current Deferred Revenue was $218222.0 for Q4 2025 at Myomo, up from $134800.0 in the prior quarter.
- Across five years, Current Deferred Revenue topped out at $218222.0 in Q4 2025 and bottomed at $747.0 in Q2 2023.
- A 5-year average of $42825.1 and a median of $12015.0 in 2024 frame the typical range for Current Deferred Revenue.
- Annual changes were most pronounced in 2021 — Current Deferred Revenue tumbled 94.51% — and 2024, when it soared 1508.43%.
- Myomo's Current Deferred Revenue stood at $1500.0 in 2021, then jumped by 1276.87% to $20653.0 in 2022, then tumbled by 58.8% to $8510.0 in 2023, then surged by 876.67% to $83115.0 in 2024, then surged by 162.55% to $218222.0 in 2025.
- Business Quant data shows MYO's Current Deferred Revenue at $218222.0 in Q4 2025, $134800.0 in Q3 2025, and $108780.0 in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Myomo | 39.24 Mn | 20.27 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 218,222.00 |
| Sep 30, 2025 | 134,800.00 |
| Jun 30, 2025 | 108,780.00 |
| Mar 31, 2025 | 129,900.00 |
| Dec 31, 2024 | 83,115.00 |
| Sep 30, 2024 | 31,971.00 |
| Jun 30, 2024 | 12,015.00 |
| Dec 31, 2023 | 8,510.00 |
| Sep 30, 2023 | 30,700.00 |
| Jun 30, 2023 | 747.00 |
| Mar 31, 2023 | 1,100.00 |
| Dec 31, 2022 | 20,653.00 |
| Sep 30, 2022 | 23,053.00 |
| Jun 30, 2022 | 2,211.00 |
| Mar 31, 2022 | 1,899.00 |
| Dec 31, 2021 | 1,500.00 |
| Sep 30, 2021 | 1,500.00 |
| Jun 30, 2021 | 1,500.00 |
| Mar 31, 2021 | 1,500.00 |
| Dec 31, 2020 | 2,512.00 |